Home › Stock analysis › STE
Steris (STE) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
STE jumps 3.3% to $224.33, a 1-month high. Closed at $224.33, +3.25% vs the prior close of $217.26. Day range $219.00–$224.51, opened at $221.81.
Last close$224.33+3.25%
Day range219.00–224.51
Open221.81
Volume838.60K
52-week range195.14–269.44
Avg volume (20d)678.38K
STE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — STE jumps 3.3% to $224.33, a 1-month high
- Closed at $224.33, +3.25% vs the prior close of $217.26. Day range $219.00–$224.51, opened at $221.81.
- Volume was 838.60K shares, 1.3x its 50-day average of 662.74K.
- Price is +1.3% vs its 50-day average ($221.53) and -0.9% vs its 200-day average ($226.40).
- 52-week range $195.14–$269.44; today's close sits at 39% of that range, 16.7% below the 52-week high.
Oct 14, 2026 — STE ends flat (-0.2%) to $217.26
- Closed at $217.26, -0.23% vs the prior close of $217.77. Day range $215.70–$219.30, opened at $217.65.
- Volume was 587.20K shares, 0.9x its 50-day average of 669.21K.
- Price is -2.0% vs its 50-day average ($221.70) and -4.1% vs its 200-day average ($226.56).
- 52-week range $195.14–$269.44; today's close sits at 30% of that range, 19.4% below the 52-week high.
Oct 13, 2026 — STE dips 0.6% to $217.77
- Closed at $217.77, -0.55% vs the prior close of $218.98. Day range $216.14–$221.45, opened at $220.21.
- Volume was 509.90K shares, 0.8x its 50-day average of 674.55K.
- Price is -1.9% vs its 50-day average ($222.01) and -4.0% vs its 200-day average ($226.75).
- 52-week range $195.14–$269.44; today's close sits at 30% of that range, 19.2% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — STE rises 2.1% to $218.98, a 1-month high, 4 up days in a row
- Closed at $218.98, +2.14% vs the prior close of $214.40. Day range $213.77–$220.75, opened at $216.09.
- Volume was 725.90K shares, 1.1x its 50-day average of 676.61K.
- Price is -1.5% vs its 50-day average ($222.31) and -3.5% vs its 200-day average ($226.94).
- 52-week range $195.14–$269.44; today's close sits at 32% of that range, 18.7% below the 52-week high.
- That makes 4 straight gains.
Oct 9, 2026 — STE rises 1.7% to $214.40, a 1-month high, 3 up days in a row
- Closed at $214.40, +1.73% vs the prior close of $210.76. Day range $209.02–$215.66, opened at $210.63.
- Volume was 597.00K shares, 0.9x its 50-day average of 681.17K.
- Price is -3.6% vs its 50-day average ($222.49) and -5.6% vs its 200-day average ($227.12).
- 52-week range $195.14–$269.44; today's close sits at 26% of that range, 20.4% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — STE rises 0.5% to $210.76
- Closed at $210.76, +0.52% vs the prior close of $209.68. Day range $207.96–$210.92, opened at $209.24.
- Volume was 498.40K shares, 0.7x its 50-day average of 689.66K.
- Price is -5.4% vs its 50-day average ($222.83) and -7.3% vs its 200-day average ($227.33).
- 52-week range $195.14–$269.44; today's close sits at 21% of that range, 21.8% below the 52-week high.
Oct 7, 2026 — STE rises 0.5% to $209.68
- Closed at $209.68, +0.49% vs the prior close of $208.65. Day range $208.37–$211.95, opened at $208.66.
- Volume was 669.80K shares, 1.0x its 50-day average of 693.73K.
- Price is -6.1% vs its 50-day average ($223.31) and -7.9% vs its 200-day average ($227.54).
- 52-week range $195.14–$269.44; today's close sits at 20% of that range, 22.2% below the 52-week high.
Oct 6, 2026 — STE dips 1.1% to $208.65
- Closed at $208.65, -1.15% vs the prior close of $211.07. Day range $207.97–$213.17, opened at $211.68.
- Volume was 909.40K shares, 1.3x its 50-day average of 689.85K.
- Price is -6.7% vs its 50-day average ($223.73) and -8.4% vs its 200-day average ($227.75).
- 52-week range $195.14–$269.44; today's close sits at 18% of that range, 22.6% below the 52-week high.
Oct 5, 2026 — STE rises 1.2% to $211.07
- Closed at $211.07, +1.21% vs the prior close of $208.54. Day range $207.46–$213.05, opened at $208.46.
- Volume was 804.10K shares, 1.2x its 50-day average of 684.00K.
- Price is -5.7% vs its 50-day average ($223.92) and -7.4% vs its 200-day average ($227.97).
- 52-week range $195.14–$269.44; today's close sits at 21% of that range, 21.7% below the 52-week high.
Oct 2, 2026 — STE dips 0.4% to $208.54, 4 down days in a row
- Closed at $208.54, -0.38% vs the prior close of $209.34. Day range $206.53–$210.27, opened at $209.64.
- Volume was 676.50K shares, 1.0x its 50-day average of 679.55K.
- Price is -6.9% vs its 50-day average ($223.98) and -8.6% vs its 200-day average ($228.18).
- 52-week range $195.14–$269.44; today's close sits at 18% of that range, 22.6% below the 52-week high.
- That makes 4 straight losses.
Things to know before you trade STE
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Feb 4, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.90% (largest 3.3%). That is a relatively calm stock.
- Liquidity: about 678.38K shares (≈$152.18M) trade per day on average.
- 52-week position: $224.33 vs a range of $195.14–$269.44 (39% of the range).
- Dividends: last ex-dividend date Sep 4, 2026 ($0.69/share); 3 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 13 sales; latest: Mohsen Sohi sold 4,058 shares on Aug 12, 2026.
- Latest filings: 8-K Oct 13, 2026; 10-Q Aug 7, 2026; 8-K Aug 6, 2026.
- Share count: 97.50M shares outstanding (Aug 4, 2026), -1.0% vs a year earlier.
- Listing: NYSE · industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
STE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 221.81 | 224.51 | 219.00 | 224.33 | 838.60K |
| Oct 14, 2026 | 217.65 | 219.30 | 215.70 | 217.26 | 587.20K |
| Oct 13, 2026 | 220.21 | 221.45 | 216.14 | 217.77 | 509.90K |
| Oct 12, 2026 | 216.09 | 220.75 | 213.77 | 218.98 | 725.90K |
| Oct 9, 2026 | 210.63 | 215.66 | 209.02 | 214.40 | 597.00K |
| Oct 8, 2026 | 209.24 | 210.92 | 207.96 | 210.76 | 498.40K |
| Oct 7, 2026 | 208.66 | 211.95 | 208.37 | 209.68 | 669.80K |
| Oct 6, 2026 | 211.68 | 213.17 | 207.97 | 208.65 | 909.40K |
| Oct 5, 2026 | 208.46 | 213.05 | 207.46 | 211.07 | 804.10K |
| Oct 2, 2026 | 209.64 | 210.27 | 206.53 | 208.54 | 676.50K |
| Oct 1, 2026 | 210.04 | 210.89 | 207.82 | 209.34 | 583.90K |
| Sep 30, 2026 | 210.69 | 212.12 | 209.49 | 210.01 | 560.80K |
| Sep 29, 2026 | 210.05 | 210.77 | 208.07 | 210.65 | 454.30K |
| Sep 28, 2026 | 208.76 | 211.63 | 206.72 | 211.00 | 493.60K |
| Sep 25, 2026 | 208.11 | 209.69 | 207.21 | 208.93 | 447.10K |
| Sep 24, 2026 | 210.05 | 211.45 | 208.57 | 208.77 | 524.40K |
| Sep 23, 2026 | 208.41 | 210.33 | 207.07 | 209.98 | 534.00K |
| Sep 22, 2026 | 208.98 | 209.12 | 205.21 | 208.79 | 624.60K |
| Sep 21, 2026 | 205.36 | 207.46 | 203.32 | 206.97 | 984.60K |
| Sep 18, 2026 | 206.24 | 207.70 | 205.00 | 205.04 | 1.54M |
About Steris
Steris (STE) is listed on the NYSE and classified by the SEC under “Orthopedic, Prosthetic & Surgical Appliances & Supplies”. Its business address is in DUBLIN, Ireland. State of incorporation: Ireland. Fiscal year ends March 31. SEC CIK 1757898.
STE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Esther M. Alegria | Director | Aug 12, 2026 |
| Pierre Boulud | Director | Aug 12, 2026 |
| Richard C Breeden | Director | Jun 4, 2026 |
| Daniel A Carestio | President and CEO | Jun 8, 2026 |
| Cynthia L Feldmann | Director | Aug 12, 2026 |
| Christopher S Holland | Director | Aug 12, 2026 |
| Paul Edward Martin | Director | Aug 12, 2026 |
| Nirav R Shah | Director | Aug 12, 2026 |
| Louis Shapiro | Director | Aug 12, 2026 |
| Mohsen Sohi | Director | Aug 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Karen L Burton | Sr. Vice Pres., CFO | Jun 8, 2026 |
| Daniel A Carestio | President and CEO | Jun 8, 2026 |
| Mary Clare Fraser | SVP & Chief HRO | Jun 8, 2026 |
| Kenneth E Kohler | SVP & GM, AST | Jun 8, 2026 |
| Julia Madsen | Sr. VP and GM, Life Sciences | Jun 8, 2026 |
| Cary L Majors | SVP and President, Healthcare | Jun 4, 2026 |
| Lindsey Mcgowan | VP, Chf. Comp. & Quality Offc. | Jun 4, 2026 |
| Renato Tamaro | V.P. & Corporate Treasurer | Jun 8, 2026 |
| John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | Jun 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 12, 2026 | Mohsen Sohi | Sale | 4,058 | $235.78 |
| Jun 15, 2026 | John Adam Zangerle | Sale | 1,419 | $209.28 |
| Jun 5, 2026 | Daniel A Carestio | Sale | 1,374 | $212.00 |
| Jun 4, 2026 | Daniel A Carestio | Sale | 3,054 | $214.64 |
| Jun 2, 2026 | Richard C Breeden | Sale | 1,481 | $209.51 |
| Mar 5, 2026 | Cynthia L Feldmann | Sale | 3,098 | $237.21 |
| Nov 21, 2025 | Julia Madsen | Sale | 2,136 | $262.00 |
| Nov 21, 2025 | Julia Madsen | Sale | 2,872 | $262.00 |
| Nov 18, 2025 | Renato Tamaro | Sale | 212 | $258.03 |
| Nov 18, 2025 | Renato Tamaro | Sale | 3,324 | $257.43 |
| Nov 18, 2025 | Renato Tamaro | Sale | 1,500 | $257.76 |
| Nov 11, 2025 | John Adam Zangerle | Sale | 15,000 | $265.14 |
| Oct 6, 2025 | Daniel A Carestio | Sale | 159 | $241.82 |
STE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Mar 31, 2026 | $5.94B | $782.30M | 7.93 | $1.34B |
| Mar 31, 2025 | $5.46B | $614.60M | 6.20 | $1.15B |
| Mar 31, 2024 | $5.14B | $378.20M | 3.81 | $973.30M |
| Mar 31, 2023 | $4.54B | $107.03M | 1.07 | $756.95M |
| Mar 31, 2022 | $4.22B | $243.89M | 2.48 | $684.81M |
Latest balance sheet: total assets $10.74B, total liabilities $3.51B, cash $482.30M (as of Jun 30, 2026).
STE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $232.71 |
| May 11, 2026 | 8-K Item 2.02 (results) | $201.85 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $264.27 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $243.18 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $221.21 |
| May 14, 2025 | 8-K Item 2.02 (results) | $227.50 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $220.83 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $227.52 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Feb 7, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
More on STE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.